The fund code for stocks on percocet

Stocks - Investing and trading for all

2008.06.27 10:43 Stocks - Investing and trading for all

Welcome on /stocks! Don't hesitate to tell us about a ticker we should know about, market news or financial education. But please, read the sidebar rules before you post. Check out our wiki to learn more!
[link]


2011.05.09 05:00 misnamed Passive Indexing Community for Long-Term Lazy Investors

Bogleheads are passive investors who follow Jack Bogle's simple but powerful message to diversify with low-cost index funds and let compounding grow wealth. Jack founded Vanguard and pioneered indexed mutual funds. His work has since inspired others to get the most out of their long-term investments. Active managers want your money - our advice: keep it! How? Investing in broad-market low-cost indexes, diversified between equities and fixed income. Buy, hold, pay low fees, and stay the course!
[link]


2012.06.17 20:13 Algorithmic Trading

A place for redditors to discuss quantitative trading, statistical methods, econometrics, programming, implementation, automated strategies, and bounce ideas off each other for constructive criticism. Feel free to submit papers/links of things you find interesting.
[link]


2024.06.05 18:38 ConflictExpensive892 New scam

New scam
Haven't seen the scan where they actually email you before.
submitted by ConflictExpensive892 to poshmarkcanada [link] [comments]


2024.06.05 18:37 skuxy18 The Dark History of Naked Short Selling

The Dark History of Naked Short Selling
In light of recent events, I highly recommend all apes, old and new to read this eye-opening article that transcribes the events of Naked Short selling and how they cull innovation and businesses since the 1980's.
link

A brief lesson in history

In the days of old, Wall Street created a system of exchanging shares via paper certificates. You would place an order to buy a share, your broker would send someone down to Wall Street, they purchase a share, and everything is accounted for.
However, in the late 60's, a paperwork crisis emerged as this process was extremely inefficient. What does the government implement? The DTC and NSCC for clearance and settlement so that we may switch our inefficient process to an electronic one. Allowing trades to be completed instantaneously.
Sounds great right? In theory, yes. But we left a gaping hole in the system. The Stock Borrow Programme.
In this new system, we now had a lending pool of shares available. The buyer (you or me) would go to the broker to purchase a stock, the broker goes to the market-maker who short-sells them the stock, and the NSCC could pull the shares from the DTCs lending pool to speed up the transaction process. The broker would then have T+3 days to settle the trade (now T+1) or face a Failure-to-deliver (FTD).

So what's the problem?

The DTC failed to put in incentives for the brokers to pay back the borrowed stock.
The brokers could take months or years to pay back the trade unless someone caught on and tried to pull every share on the market. And this would never happen. The result is a perfect system for manipulating and naked-short selling.
Now, you have a system where there is an entire lending pool and the ability for market-makers to pull shares from the lending pool to loan to Broker A, B, or C. Creating multiples of more shares than exist in the float
Self-Replenishing pool theory
Now on to how this all works.
Buyer A asks Broker A to purchase 1000 shares of Stock XYZ at $1 per share.
Broker A goes to the Market-Maker with our $1k.
Market-Maker confirms the purchase of the trade without locating the shares first! and fills the order.
When the trade FTDs in T+1 because the MM has not located the shares, it reaches into DTCCs lending pool via stock borrow programme.
The DTCC sees that share exist in Broker Bs account, and uses them to fill.
But, Broker B got their shares from Investor Bs account.
Now you have 2,000 shares. 1k in Buyer A's account and 1k in Investor Bs account.
Reports suggest the DTCC does not keep track of how long these shares are lent out, so there is no pressure or cost to fill. Now with the CAT. We should get an audit trail to where these shares are.
This is how more shares are able to trade and short stocks than actually exist. This is also why DRSing is crucial.

How this played out in the real world.

Hedge Funds catch on quickly, and begin shorting small-cap stocks which fly under the radar and are undervalued. Because there is an ability to create more shares than actually exist, Hedge Funds can take advantage of the slightest bad news, and short the stock over 100% of their float into oblivion.
This causes a crisis of culling innovation in US markets.
Microsoft, Dell, Oracle, and Cisco started as pink-sheet stocks. All companies that fit the bill of naked short selling for these hedge funds. What if they had been shorted into oblivion? How many other companies suffered that could have changed the world?

What's next?

GameStop baby. These fuckers are stuck bag-holding a company that is no longer going to $0. Their hail mary was doubling-down on the shorts after Jan 2021, and spreading misinformation that the stock was dying and that everyone should exit. Thanks to RC, DFV and you beautiful apes, we didn't fucking sell.
Now they are stuck paying premiums out the ass for FTDs, on a company that is growing and will not go to $0. The result will be a squeeze as they have no option other than to buy back their shares on loan used for shorting eventually.
They are losing money both on the FTDs and on naked shorts. The only two options are to:
  1. Kick the can down the road until they squeeze harder
  2. Squeeze now
In either scenario, there will be a catalyst. And we are getting closer and closer to it.
TL:DR
Naked-Short-Selling dates back as early as 1981. Thousands of US companies have been culled due to these illegal tactics by hedge-funds, allowed by a incomplete stock borrow programme. As a result, naked short selling has run rampant in US stock market history. GameStop is the first incident where we have a stock that will not go to $0, and a shit ton of eyes on the situation. This is no small-cap, under the radar stock anymore. The only outcome is a short-squeeze.
submitted by skuxy18 to Superstonk [link] [comments]


2024.06.05 18:37 littlezappa Webull Canada Referral Code - Sign up and get a $50 Bonus when you fund atleast 100 dollars

WeBull is now in Canada and here is my Referral Code for $50 when you deposit atleast 100 dollars. You also get and get 90 days of commission FREE trading on US and Canada equities. And 4% interest on your balance.
Webull is a zero commission trading platform where you can buy, sell, invest into stocks and other commodities
 
https://www.webull.ca/s/U2GcaNWBxdBIOtnA2g
 
Make sure to sign up and complete verification/funding promptly since these bonuses do not last long before they expire. Also, the sign up page will have more details on the offer and additional bonus details
submitted by littlezappa to referralcodes [link] [comments]


2024.06.05 18:35 Maskekar [TH] 6.6 Flash Day for Slots

[TH] 6.6 Flash Day for Slots
  • Region: TH
  • Promotion Period: Effective on 6th June 2024, 00:00:00 to 23:59:59 (GMT +7)
6.6 Flash Day for Slots
It’s raining cash! Get Mega Bonus of THB 750 when you play Slots!
Join BK8 Now to be eligible!
Event Details
Details
How to Apply
  • All THB account members are entitled to this promotion.
  • Members are required to deposit/transfer a minimum of THB 1,000 to PG Soft slots provider wallet during promotion period to be eligible for bonus.
  • Only a transfer of exactly THB 1,000 into PG Soft wallet is allowed.
  • Go to [Transfer] page, select “Transfer”.
  • Enter the amount THB 1,000 from “Main Wallet” to [PG Soft] slots provider wallet.
  • Select the [6.6 Hi Rainy] from the promo code dropdown menu.
Terms and Conditions
  • This promotion is for PG Soft only.
  • Members are required to fulfil 8x turnover of total deposit and bonus amount in order to withdraw.
  • Each member is entitled to a maximum of ONE (1) bonus during the promotion period.
  • No rebates are entitled under this promotion.
  • Bonuses are valid for seven (7) days upon issuance unless stated otherwise. Money won using bonus funds will be removed from the member’s account if prerequisites are not fulfilled within the given time frame. Any attempts to withdraw funds before fulfilling turnover requirements or early cash out will automatically cancel the bonus, any associated promotions and any winnings from the bonus.
  • This promotion cannot be used in conjunction with other BK8 promotions.
  • BK8 reserves the right to modify, cancel, suspend, or terminate the promotion and/or change the terms of the promotion at any time without prior notice.
  • BK8 is the sole arbiter of the promotion, and its decision is final.
  • Participating members must accept and comply with all the terms mentioned above as well as all relevant rules and regulations stated on the BK8 website.
  • General BK8 Terms & Conditions apply.
submitted by Maskekar to BK8_Forum [link] [comments]


2024.06.05 18:33 mattschinesefood Customizing unisex clothing product from China (Alibaba) - getting started questions.

Hi all. I've stumbled upon a unisex clothing / accessory product that I think would be a great fit for a niche sport I’m into. I've never purchased / worked with anyone off Alibaba before, and I'm looking for some insights. My out-of-pocket starting budget is up to $2000 USD, however I'd prefer to keep it closer to $1000. Details are below, but I'm looking for any and all feedback, insight, etc.
Product Let's start with the product. I won't go into specifics, but it's a unisex clothing product that will need to come in multiple sizes - assuming two different product colors/designs, I'm looking at 20 SKUs total (10 in each design).
There are people selling this product under Chinese-brand-sounding names on Amazon, but not specifically targeting my niche in any way. I've already purchased this product from a couple different Amazon sellers and I'm satisfied with the quality and use case I have in mind, and believe it’s a great product for the niche. Almost all changes to the product I would want to make would be branding/coloaesthetic. The only core product changes I would want to make (at least initially) would just be wrangling in a few small quality things. Amazon price points are between $18 and $30 per unit.
I've found several suppliers on Alibaba for this product, both variations of what I've purchased off Amazon as well as the exact product. Advertised price point on Alibaba starts at $8.00 per unit (for up to 600 units), down to $6.00 per unit (for over 1000 units).
Product Changes I would be looking for 90% brand/colodesign-related changes, and 10% changes to quality control.
Pricing I like to assume and plan for a "worst case" when budgeting things in life. Assuming a cost for me of $9.00 per unit, I would be targeting a selling price of between $30 to $40 per unit. Let’s call it $35 for the first run This means ~288% markup and 74% profit margin per unit. I’d be happy with that to start, but I don’t really know what constitutes a “good” profit margin on such a product?
Web presence & Testing Interest I've already registered my TLD and creating a basic landing page which right now has some generic product photos pulled from Alibaba, product copy, and a mailing list signup.
I’m planning on integrating a simple ecomm to this to place a preorder, and use those preorder funds to help fund the initial batch of product. Will throw in something like “special 15% off preorder price” to make it more attractive.
Market Research So I know I like it, big whoop. I need real, tangible input from real people into the sport. My first step will be finding some local folks into the sport, giving them free products and in exchange letting me photo/film them using it and get their feedback.
If the feedback is good, then I’m going to reach out to micro influencers on IG with the same deal (provide feedback, maybe shoot some quick footage of them using it/recommending it for my use later). Give them branded discount codes to share.
Marketing Like many products, social media will be only of my biggest tools here, with Instagram being the biggest one. I’ve got an IG and FB account created, however I’m personally HORRIBLE at content creation. Like, awful. I really don’t know what to do here to fix that.
See the micro-influencers paragraph above - I would ask that they market and share, and come up with a program to compensate them for each order using their discount code. I am unsure what percentages should look like on this.
There are also several aftermarket companies in this sport that have great followings, and I would like to contact them to try to spread the word about the product. This would involve free product to them, and a basic reseller agreement. I still need to look into how to handle that aspect.
Questions / things that I have (in no specific order): 1. How do I even go about starting to contact suppliers on Alibaba? I’m guessing it’s just “create an account, add details, and message them”? Any suggestions on messaging, what to include, etc? 2. I’ve always struggled with my own self-doubt (who hasn’t?). I don’t know how to get around my train of thought of “people will just see this product and Google it, find other Amazon/Aliexpress listings that are cheaper and buy it from them. Why would they buy it from me?” because that’s exactly what I would do. I tend to go nuts bloodhounding trying to find the source for any product and buy it cheaper and while I know that logically the greater majority of people don’t do this, I still unreasonably worry they will. 3. Should I focus on dropshipping these? Or would it be better to bulk ship them to me and mail them myself? Obviously that would add a lot of cost and overhead, which eats into margins significantly. The product would fit into a small USPS flat rate box, which is $4.95 to ship anywhere in the US. Let’s add in a ‘thank you’ note of some sort and a sticker. Assume 2 ‘thank yous’ per page at $0.68 per page, plus $1 per sticker. This effectively brings my cost to $15.29 per unit (assuming $30 preorder price), meaning profit margin is now $56.31. Dropshipping on the other hand means it shows up with random customs stickers, potentially missing packages, increased shipping time, etc. 4. What should I expect from Alibaba negotiations?
Please critique away. Any and all feedback is helpful.
submitted by mattschinesefood to Entrepreneur [link] [comments]


2024.06.05 18:32 mattschinesefood Customizing unisex clothing product from China (Alibaba) - getting started questions.

Hi all. I've stumbled upon a unisex clothing / accessory product that I think would be a great fit for a niche sport I’m into. I've never purchased / worked with anyone off Alibaba before, and I'm looking for some insights. My out-of-pocket starting budget is up to $2000 USD, however I'd prefer to keep it closer to $1000. Details are below, but I'm looking for any and all feedback, insight, etc.
Product Let's start with the product. I won't go into specifics, but it's a unisex clothing product that will need to come in multiple sizes - assuming two different product colors/designs, I'm looking at 20 SKUs total (10 in each design).
There are people selling this product under Chinese-brand-sounding names on Amazon, but not specifically targeting my niche in any way. I've already purchased this product from a couple different Amazon sellers and I'm satisfied with the quality and use case I have in mind, and believe it’s a great product for the niche. Almost all changes to the product I would want to make would be branding/coloaesthetic. The only core product changes I would want to make (at least initially) would just be wrangling in a few small quality things. Amazon price points are between $18 and $30 per unit.
I've found several suppliers on Alibaba for this product, both variations of what I've purchased off Amazon as well as the exact product. Advertised price point on Alibaba starts at $8.00 per unit (for up to 600 units), down to $6.00 per unit (for over 1000 units).
Product Changes I would be looking for 90% brand/colodesign-related changes, and 10% changes to quality control.
Pricing I like to assume and plan for a "worst case" when budgeting things in life. Assuming a cost for me of $9.00 per unit, I would be targeting a selling price of between $30 to $40 per unit. Let’s call it $35 for the first run This means ~288% markup and 74% profit margin per unit. I’d be happy with that to start, but I don’t really know what constitutes a “good” profit margin on such a product?
Web presence & Testing Interest I've already registered my TLD and creating a basic landing page which right now has some generic product photos pulled from Alibaba, product copy, and a mailing list signup.
I’m planning on integrating a simple ecomm to this to place a preorder, and use those preorder funds to help fund the initial batch of product. Will throw in something like “special 15% off preorder price” to make it more attractive.
Market Research So I know I like it, big whoop. I need real, tangible input from real people into the sport. My first step will be finding some local folks into the sport, giving them free products and in exchange letting me photo/film them using it and get their feedback.
If the feedback is good, then I’m going to reach out to micro influencers on IG with the same deal (provide feedback, maybe shoot some quick footage of them using it/recommending it for my use later). Give them branded discount codes to share.
Marketing Like many products, social media will be only of my biggest tools here, with Instagram being the biggest one. I’ve got an IG and FB account created, however I’m personally HORRIBLE at content creation. Like, awful. I really don’t know what to do here to fix that.
See the micro-influencers paragraph above - I would ask that they market and share, and come up with a program to compensate them for each order using their discount code. I am unsure what percentages should look like on this.
There are also several aftermarket companies in this sport that have great followings, and I would like to contact them to try to spread the word about the product. This would involve free product to them, and a basic reseller agreement. I still need to look into how to handle that aspect.
Questions / things that I have (in no specific order): 1. How do I even go about starting to contact suppliers on Alibaba? I’m guessing it’s just “create an account, add details, and message them”? Any suggestions on messaging, what to include, etc? 2. I’ve always struggled with my own self-doubt (who hasn’t?). I don’t know how to get around my train of thought of “people will just see this product and Google it, find other Amazon/Aliexpress listings that are cheaper and buy it from them. Why would they buy it from me?” because that’s exactly what I would do. I tend to go nuts bloodhounding trying to find the source for any product and buy it cheaper and while I know that logically the greater majority of people don’t do this, I still unreasonably worry they will. 3. Should I focus on dropshipping these? Or would it be better to bulk ship them to me and mail them myself? Obviously that would add a lot of cost and overhead, which eats into margins significantly. The product would fit into a small USPS flat rate box, which is $4.95 to ship anywhere in the US. Let’s add in a ‘thank you’ note of some sort and a sticker. Assume 2 ‘thank yous’ per page at $0.68 per page, plus $1 per sticker. This effectively brings my cost to $15.29 per unit (assuming $30 preorder price), meaning profit margin is now $56.31. Dropshipping on the other hand means it shows up with random customs stickers, potentially missing packages, increased shipping time, etc. 4. What should I expect from Alibaba negotiations?
Please critique away. Any and all feedback is helpful.
submitted by mattschinesefood to smallbusiness [link] [comments]


2024.06.05 18:32 Syndicate_Corp 401k - Fidelity FBCGX - Price reporting issue

Sort of an odd situation here, I’ve got some FBCGX (Fidelity Blue Chip Growth k6) and it’s not reporting the price changes this week?
I understand the fund is not an ETF so daily results are posted ~9PM EST or early morning next day. However, the price is showing as $32.18 for both 6/3 and 6/4. Given that this is a primarily tech focused stock and the recent volatility/subsequent rallies, it doesn’t make sense the stock price wouldn’t change even 1 cent? It says 0% change.
Anyone else own the stock/what are you seeing for price reporting on your end?
submitted by Syndicate_Corp to investing [link] [comments]


2024.06.05 18:16 Comfortable_Pay_2582 Does it make sense to have a non-retirement brokerage account?

I have a 401(k) and Roth IRA with Schwab. I also have an individual brokerage account where I trade most of the same mutual funds and etfs as the two retirement accounts, plus some stocks that I’ve had for a while. Are the gains on the mutual funds, etfs, and stock options taxed differently in my individual brokerage account than my retirement accounts? And if not, does it make sense to invest more money in there?
I don’t have any short term goals. I have long term goals (5+ years out) like a house and such, but wonder if it makes sense to sell what I have in the individual account and put that in my HYSA or a CD? Or let the mutual funds and etfs ride out for 5+ years?
submitted by Comfortable_Pay_2582 to Schwab [link] [comments]


2024.06.05 18:14 littlezappa Join Wealthsimple and Get a Bonus ($25 for you and $25 for me) or (Up to $250 for Premium or $1000 for Generation) Including Previous Non Referred Members 🍁

Wealthsimple is Canada's first $0 commission stock trading app – sign up now using my referral code and we'll both Get a Bonus ($25 for you and $25 for me) to trade. Must fund at least one dollar.
 
Now also includes crypto trading. So if you are not into stocks, you can purchase some crypto and still get the bonus.
 
CODE: US0EBW
 
Link: https://my.wealthsimple.com/app/public/trade-referral-signup?code=US0EBW
 
Bonus: Since I am a premium client, we will both get our reward boosted to $250 if you also become a Premium client within 30 days and $1,000 if you reach Generation.
 
Wealthsimple Cash (Their prepaid card) is also now integrated into the app
submitted by littlezappa to referralcodes [link] [comments]


2024.06.05 18:09 MightBeneficial3302 NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials (TSXV: NRX, OTCQB: NRXBF, FSE: J90, NRX.V)

NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials (TSXV: NRX, OTCQB: NRXBF, FSE: J90, NRX.V)

https://preview.redd.it/ssj9aa2x1s4d1.png?width=300&format=png&auto=webp&s=65a900abd2aa90a39d2a8aacfaa0facfaa3a917d
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies, is pleased to announce its financial and operational results for the three months ended March 31, 2024, the highlights of which are included in this news release. The Company’s full set of consolidated financial statements for the three months ended March 31, 2024, and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.nurexone.com and its profile page on SEDAR+ at www.sedarplus.ca.
Key Business Highlights
On March 1, 2024, the Company commenced the setup of in-house laboratories and offices to bolster its research and development capabilities, subsequent to entering into lease and construction agreements. Completion of these initiatives is anticipated by the end of June 2024.
On March 22, 2024, the Company completed the acceleration of 12,682,340 warrants issued pursuant to a private placement of units that closed on June 15, 2022. Following the acceleration event, the Company received gross proceeds of US$2.92 million (approximately C$4.0 million) from the exercise of 10,423,629 common share purchase warrants, which represented accelerated and non-accelerated warrants of which 9,684,993 warrants were exercised at a price of C$0.38, 556,818 warrants were exercised at a price of C$0.34, and 181,818 warrants were exercised at a price of C$0.48. The Company exercised its right to accelerate the expiry date of certain warrants to thirty days upon the Company’s common shares exceeded C$0.475 for ten consecutive trading days on the TSX Venture Exchange (“TSXV”). “We appreciate the confidence of the investors who exercise their warrants, and the ongoing support of NurExone’s journey,” stated Eran Ovadya, NurExone Chief Financial Officer.
On April 1, 2024, the Company entered into a Contract Research Organization services agreement with Vivox Ltd. for animal experiments as part of the preclinical testing phase for the submission of an Investigational New Drug (“IND”) application to the United States Food and Drug Administration (the “FDA”). This is aimed at assessing the safety and efficacy of the ExoPTEN drug before proceeding to clinical trials involving human subjects, which are anticipated to commence in 2025. This engagement followed the completion of a Pre-IND meeting with the FDA regarding the manufacturing, preclinical, and clinical development plan of ExoPTEN, NurExone’s inaugural ExoTherapy product, and the subsequent receipt of a written response from the FDA.
On April 25, 2024, NurExone successfully secured approval for listing on the OTCQB Venture Market, marking a significant milestone in the Company's growth and visibility within the financial community, including in the USA. In addition, the Company achieved Depository Trust Company eligibility, which enhances the efficiency and cost-effectiveness of trading NurExone shares, facilitating better liquidity and broader access for investors.
Growth Outlook for 2024
According to Chief Executive Officer Dr. Lior Shaltiel, “NurExone is committed to pioneering transformations in the field of regenerative medicine with new, minimally invasive therapies and we are moving along the regulatory path towards human trials for our first product, ExoPTEN. Our focus remains on enhancing our ExoTherapy platform for the production of nanodrugs, expanding our intellectual property, and forging strategic collaborations. Towards this end, we have recently engaged Dr. Ram Petter, Vice President and head of Bio Strategy at Teva Pharmaceutical, to support our efforts in collaborating with biopharma companies.”
First Quarter Fiscal 2024 Financial Results
  • Research and development expenses were US$0.22 million in the first quarter of 2024, compared to US$0.37 million in the same quarter in 2023. The decrease was primarily due to the receipt of a governmental grant of US$0.02 and reductions in stock-based compensation of US$0.08, subcontractor and materials expenses of US$0.05.
  • General and administrative expenses were US$0.70 million in the first quarter of 2024, compared to US$0.35 million in the same period in 2023. The increase was primarily due to costs related to public and investor relations services.
  • Finance expenses were US$0.01 million in the first quarter of 2024, compared to finance income of US$0.01 million in the same period in 2023, driven by income from bank interest.
  • Net loss was US$0.92 million in the first quarter of 2024, compared to a net loss of US$0.70 million in the first quarter of 2023.
As of March 31, 2024, the Company had cash and cash equivalents of US$3.25 million (December 31, 2023 - US$0.54 million) and working capital of US$3.31 million (December 31, 2023 - US$0.07 million). The increase in cash was primarily due to the completion of a private placement in January 2024 for gross proceeds of approximately US$1.49 million and the exercise of warrants in March 2024 for gross proceeds of approximately US$2.92 million.
The Company had an accumulated deficit of US$14.98 million as of March 31, 2024, (December 31, 2023 - US$14.06 million).
Eran Ovadya, NurExone’s Chief Financial Officer, added: “The Company maintains a strong cash position, ensuring sufficient funding until year-end. With strategic oversight, we navigate our business plan amidst ongoing activities, positioning ourselves for sustained growth and continued success.”
About NurExone Biologic Inc.
NurExone Biologic Inc. is a TSXV listed pharmaceutical company that is developing a platform for biologically-guided exosome-based therapies to be delivered, non-invasively, to patients who have suffered Central Nervous System injuries. The Company’s first product, ExoPTEN for acute spinal cord injury, was proven to recover motor function in 75% of laboratory rats when administered intranasally. ExoPTEN has been granted Orphan Drug Designation by the FDA. The NurExone platform technology is expected to offer novel solutions to drug companies interested in noninvasive targeted drug delivery for other indications.
For additional information, please visit www.nurexone.com or follow NurExone on LinkedIn, Twitter, Facebook, or YouTube.
For more information, please contact:
Dr. Lior Shaltiel Chief Executive Officer and Director Phone: +972-52-4803034 Email: info@nurexone.com
Thesis Capital Inc. Investment Relation - Canada Phone: +1 905-347-5569 Email: IR@nurexone.com
Dr. Eva Reuter Investment Relation - Germany Phone: +49-69-1532-5857 Email: e.reuter@dr-reuter.eu
submitted by MightBeneficial3302 to Wealthsimple_Penny [link] [comments]


2024.06.05 18:09 MightBeneficial3302 NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials (TSXV: NRX, OTCQB: NRXBF, FSE: J90, NRX.V)

NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials (TSXV: NRX, OTCQB: NRXBF, FSE: J90, NRX.V)

https://preview.redd.it/skjldluv1s4d1.png?width=300&format=png&auto=webp&s=703ab35b18988abdd8254bc99f308cc1ad824f32
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies, is pleased to announce its financial and operational results for the three months ended March 31, 2024, the highlights of which are included in this news release. The Company’s full set of consolidated financial statements for the three months ended March 31, 2024, and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.nurexone.com and its profile page on SEDAR+ at www.sedarplus.ca.
Key Business Highlights
On March 1, 2024, the Company commenced the setup of in-house laboratories and offices to bolster its research and development capabilities, subsequent to entering into lease and construction agreements. Completion of these initiatives is anticipated by the end of June 2024.
On March 22, 2024, the Company completed the acceleration of 12,682,340 warrants issued pursuant to a private placement of units that closed on June 15, 2022. Following the acceleration event, the Company received gross proceeds of US$2.92 million (approximately C$4.0 million) from the exercise of 10,423,629 common share purchase warrants, which represented accelerated and non-accelerated warrants of which 9,684,993 warrants were exercised at a price of C$0.38, 556,818 warrants were exercised at a price of C$0.34, and 181,818 warrants were exercised at a price of C$0.48. The Company exercised its right to accelerate the expiry date of certain warrants to thirty days upon the Company’s common shares exceeded C$0.475 for ten consecutive trading days on the TSX Venture Exchange (“TSXV”). “We appreciate the confidence of the investors who exercise their warrants, and the ongoing support of NurExone’s journey,” stated Eran Ovadya, NurExone Chief Financial Officer.
On April 1, 2024, the Company entered into a Contract Research Organization services agreement with Vivox Ltd. for animal experiments as part of the preclinical testing phase for the submission of an Investigational New Drug (“IND”) application to the United States Food and Drug Administration (the “FDA”). This is aimed at assessing the safety and efficacy of the ExoPTEN drug before proceeding to clinical trials involving human subjects, which are anticipated to commence in 2025. This engagement followed the completion of a Pre-IND meeting with the FDA regarding the manufacturing, preclinical, and clinical development plan of ExoPTEN, NurExone’s inaugural ExoTherapy product, and the subsequent receipt of a written response from the FDA.
On April 25, 2024, NurExone successfully secured approval for listing on the OTCQB Venture Market, marking a significant milestone in the Company's growth and visibility within the financial community, including in the USA. In addition, the Company achieved Depository Trust Company eligibility, which enhances the efficiency and cost-effectiveness of trading NurExone shares, facilitating better liquidity and broader access for investors.
Growth Outlook for 2024
According to Chief Executive Officer Dr. Lior Shaltiel, “NurExone is committed to pioneering transformations in the field of regenerative medicine with new, minimally invasive therapies and we are moving along the regulatory path towards human trials for our first product, ExoPTEN. Our focus remains on enhancing our ExoTherapy platform for the production of nanodrugs, expanding our intellectual property, and forging strategic collaborations. Towards this end, we have recently engaged Dr. Ram Petter, Vice President and head of Bio Strategy at Teva Pharmaceutical, to support our efforts in collaborating with biopharma companies.”
First Quarter Fiscal 2024 Financial Results
  • Research and development expenses were US$0.22 million in the first quarter of 2024, compared to US$0.37 million in the same quarter in 2023. The decrease was primarily due to the receipt of a governmental grant of US$0.02 and reductions in stock-based compensation of US$0.08, subcontractor and materials expenses of US$0.05.
  • General and administrative expenses were US$0.70 million in the first quarter of 2024, compared to US$0.35 million in the same period in 2023. The increase was primarily due to costs related to public and investor relations services.
  • Finance expenses were US$0.01 million in the first quarter of 2024, compared to finance income of US$0.01 million in the same period in 2023, driven by income from bank interest.
  • Net loss was US$0.92 million in the first quarter of 2024, compared to a net loss of US$0.70 million in the first quarter of 2023.
As of March 31, 2024, the Company had cash and cash equivalents of US$3.25 million (December 31, 2023 - US$0.54 million) and working capital of US$3.31 million (December 31, 2023 - US$0.07 million). The increase in cash was primarily due to the completion of a private placement in January 2024 for gross proceeds of approximately US$1.49 million and the exercise of warrants in March 2024 for gross proceeds of approximately US$2.92 million.
The Company had an accumulated deficit of US$14.98 million as of March 31, 2024, (December 31, 2023 - US$14.06 million).
Eran Ovadya, NurExone’s Chief Financial Officer, added: “The Company maintains a strong cash position, ensuring sufficient funding until year-end. With strategic oversight, we navigate our business plan amidst ongoing activities, positioning ourselves for sustained growth and continued success.”
About NurExone Biologic Inc.
NurExone Biologic Inc. is a TSXV listed pharmaceutical company that is developing a platform for biologically-guided exosome-based therapies to be delivered, non-invasively, to patients who have suffered Central Nervous System injuries. The Company’s first product, ExoPTEN for acute spinal cord injury, was proven to recover motor function in 75% of laboratory rats when administered intranasally. ExoPTEN has been granted Orphan Drug Designation by the FDA. The NurExone platform technology is expected to offer novel solutions to drug companies interested in noninvasive targeted drug delivery for other indications.
For additional information, please visit www.nurexone.com or follow NurExone on LinkedIn, Twitter, Facebook, or YouTube.
For more information, please contact:
Dr. Lior Shaltiel Chief Executive Officer and Director Phone: +972-52-4803034 Email: info@nurexone.com
Thesis Capital Inc. Investment Relation - Canada Phone: +1 905-347-5569 Email: IR@nurexone.com
Dr. Eva Reuter Investment Relation - Germany Phone: +49-69-1532-5857 Email: e.reuter@dr-reuter.eu
submitted by MightBeneficial3302 to 10xPennyStocks [link] [comments]


2024.06.05 18:07 Life_Researcher4882 EVERYONE with FFIE Must Do THIS NoW…..

EVERYONE with FFIE Must Do THIS NoW…..
Everyone should do this right now! Just went to the SEC.gov and went to CONTACT Section. and wrote every commissioner the following email.
Dear SEC Officials,
My name is James, and I am writing to bring to your attention a series of illegal practices occurring against the stock FFIE (Faraday Futures) over the past several weeks. The frequency and magnitude of these actions have become alarming and are impossible to overlook. I am in the process of compiling a comprehensive report detailing each instance of these illegal activities, which appear to be perpetrated by certain hedge funds and other entities. This report will be made public to ensure transparency and accountability. The evidence is overwhelming and easily accessible to anyone who invests even a few moments to investigate. I have a substantial online following of over 600,000 individuals who deserve to know the truth about the corruption impacting retail investors. While I understand the SEC’s role in regulating the industry, the blatant nature of these activities cannot be ignored any longer. The retail investor community is counting on you to uphold market integrity and fairness. Please take immediate action to investigate and halt these corrupt practices. The trust and confidence of retail investors are at stake, and we deserve better than this…. Thank you for your attention to this critical matter!
submitted by Life_Researcher4882 to FFIE [link] [comments]


2024.06.05 18:05 hivincentc What's happening in the markets: June 5th

Good morning. US stock futures moved higher in Wednesday morning trading as investors geared up for private payroll data while analyzing the latest corporate earnings.
S&P 500 +0.19% Dow +0.10% Nasdaq +0.41%
💸 UN sounds alarm on global debt level
*📝 Our report: *Global public debt hit a whopping $97 trillion last year, the UN reported, with developing countries owing about a third of that — crimping their ability to pay for basic government services like health care, education and climate action. In its report entitled “A World of Debt," the UN Trade and Development agency, formerly known as UNCTAD, said high interest payments are outstripping growth in essential public spending.
🔑 Key points:
*💡 So what: *The implications of global public debt reaching a record high of $97 trillion are multifaceted, affecting economic stability and development, particularly in developing countries which owe about one-third of this debt. High debt levels strain government budgets, diverting resources from essential services like healthcare and education, and increasing the risk of default, which can destabilize global financial markets. Additionally, high debt can impact sovereign credit ratings, raising borrowing costs and creating a cycle of higher debt and interest payments, posing significant ethical concerns about intergenerational equity and the sustainability of current fiscal policies.
🖥️ Microsoft makes moves to resolve EU antitrust concerns
WHAT: Microsoft's President Brad Smith hinted that the company plans more moves to settle the EU's antitrust probe into Teams, despite likely facing charges. The European Commission launched an investigation into Microsoft's tying of Office and Teams last year, following a 2020 complaint by Salesforce-owned Slack, a competing workspace messaging app.
WHY: Microsoft in April said it would sell its chat and video app Teams separately from its Office product globally, months after it unbundled the two products in Europe in a bid to avert a possible EU antitrust fine.
📺 Canada ramps up tax on online streaming services
WHAT: Canada's telecoms regulator has decreed that major streaming services must chip in 5% of their Canadian earnings to bolster the domestic broadcasting system. The Canadian Radio-television and Telecommunications Commission (CRTC) said the money would be used to boost funding for local and aboriginal broadcasting. The measure would raise roughly C$200 million ($146 million) a year, they said.
WHY: The measure was introduced under the auspices of a law passed last year designed to make sure that firms like Netflix and Alphabet Inc-owned YouTube make more of a contribution to Canadian culture.
🤖 Tech company spends big on AI startups
WHAT: Cisco Systems is betting a cool $1 billion on startups crafting "secure and reliable" AI services, aiming to level up its game in the AI arena. “AI is reshaping every industry across the globe at an unprecedented pace. Some of the investments that we’re going to make will be followed by some partnership agreements” Cisco’s Chief Strategy Officer Mark Patterson said in an interview.
WHY: Like other Silicon Valley mainstays, Cisco is looking for ways to tap into the frenzy of interest in AI computing. It’s already incorporated the software into some products, including its well-known Webex conferencing service, and has announced a tie-up with Nvidia to sell products based on that company’s chips.
submitted by hivincentc to FluentInFinance [link] [comments]


2024.06.05 18:03 mwaddmeplz Thank you MK Sharren Haskel

https://nationalpost.com/news/canada-turned-its-back-on-israel-says-visiting-israeli-legislator
She is 100% spot on that our failing government that has turned the Canadian economy into a basket case, presided over record high spending and debt, and burned bridges and turned us into a laughing stock is failing and has betrayed Israel
We 100% should NOT be funding UNRWA Hamas terrorists, we SHOULD be cracking down on pro Hamas encampments and protests by naive, ignorant, and indoctrinated young people that call for the destruction of Israel, glorify terrorism, and praise proscribed terrorist organisations, and we should not even entertain recognising 'Palestine' while Hamas has any role to play in governing it.
As a Canadian, I am proud to stand with Israel 100% and am ashamed of our government that is in bed with far left radicals who hate Israel and whose PM has a spine made of jelly
submitted by mwaddmeplz to Israel [link] [comments]


2024.06.05 17:36 J_R_D_N Shorts have passed the event horizon

Shorts have passed the event horizon
Some of you still believe shorts will be able to escape this either by their continued illegal tactics or by staging some event they can blame this on.
They will play dirty. They will stomp and shout claiming manipulation, but there is nothing they can do... Roaring Kitty (RK) has significantly increased his holdings over the past 3 years, now with cash on hand equal to his total portfolio in April 2021. His portfolio has seen a 525% increase. RK meticulously follows stock and market trends, leveraging options volatility arbitrage strategies to build his position. He was likely behind the significant options moves in late April and early May, strategically planning his return to coincide with meme tweets to create a positive feedback loop. RK's hands are clean. He is playing according to their rules within this "fair" market.
Shout out to Peruvian Bull for his explanation on thishttps://www.reddit.com/Superstonk/comments/1d7y5t0/peruvial_bulL_on_roaring_kitty_calls_hes_building/
Roaring Kitty's position is acting as a “call wall”. Not being able to suppress the price, market makers HAVE to buy the underlying stock to hedge their risk, which drives up the stock price. This forces shorts to perpetually hedge to stay alive.
https://preview.redd.it/ewmsbg3x4r4d1.png?width=561&format=png&auto=webp&s=b6dde2b758ddba0e14d39af578ef17f05556b65f
The SEC’s CAT system’s Compliance Go-Live date was May 31, 2024. If you dont know by now, this system tracks all order and trading activity in the U.S. markets, enhancing oversight and transparency. This is over 10 YEARS in the making and you are telling me the CAT deployment coincides with Roaring Kitty’s resurgence and significant call option buys???
Industry Recommendations for the Creation of a Consolidated Audit Trail (CAT) dated: March 28, 2013
It is fully plausible that the SEC and DOJ have been in communication with Roaring Kitty for some time, ensuring they have the proper oversight tools to catch market manipulation by MM's and hedge funds.
https://preview.redd.it/ledyrel5nr4d1.png?width=828&format=png&auto=webp&s=dccfe58fbd9c92b1e4616fe4bba024337e88df4b
His return, while strategically timed, will continue to expose vulnerabilities that have always existed. We have already won.
Edit: Just saw this
Gary Gensler on MSMBC discussing market regulation with the Rat 6/5/24
"The SEC runs a civil law enforcement agency and you expect us to investigate where we investigate but we dont talk about it publicly.."
"Public disclosure is really important to our Capital Markets" - Gary Gensler
submitted by J_R_D_N to Superstonk [link] [comments]


2024.06.05 17:27 Exotic_Sector7410 What are the most trusted proprietary trading firms for traders in 2024?

Determining the absolute "most trusted" prop firm can be subjective as experiences can vary. However, here are some reputable prop trading firms for traders in 2024, along with some factors to consider when choosing one:
Well-Regarded Prop Firms:
Factors to Consider When Choosing a Prop Firm:
Additional Tips:
Remember: Prop trading can be a high-risk, high-reward endeavor. Do your due diligence, prioritize risk management, and choose a firm that aligns with your goals and experience level.
submitted by Exotic_Sector7410 to forexvsstock [link] [comments]


2024.06.05 17:26 Smok3dSalmon Jim Cramer appreciation post

I'd just like to take a moment to thank Jim Cramer for a decade plus of market manipulation. If it weren't for his blatant and openly corrupt behavior, I don't think hedge funds would have ever had the maniacal ego to dig themselves into such a massive hole.
These hedge funds feasted on brick n mortar companies that were caught flat footed and hadn't pivoted to the internet era fast enough. The hedge funds attacked these companies with naked shorts, overpaid consultants, and media FUD.
Well it seems that we have caught these hedge funds flat footed. They didn't pivot to the internet either. They continued to captivate their boomer audience and swindled them into underperforming the S&P. They did this on the TV! The fucking TELEVISION.
Jim, if you're reading this, it's time for you to go now. You're fucking washed mate.
Sincerely, A man who likes the stock.
https://m.youtube.com/watch?v=8DJlogbrDcA
submitted by Smok3dSalmon to Superstonk [link] [comments]


2024.06.05 17:23 Exotic_Sector7410 What are the main books required to master the trading and investing?

There is no single set of books that will guarantee mastery of trading and investing, but here are some highly regarded resources that can provide a strong foundation:
It's important to remember that these are just a starting point. There are many other great books on trading and investing available. The best approach is to read widely and develop a well-rounded understanding of the markets.
Here are some additional tips for choosing books on trading and investing:
By following these tips, you can find the best books to help you on your journey to becoming a successful trader or investor.
submitted by Exotic_Sector7410 to forexvsstock [link] [comments]


2024.06.05 17:23 seemsdicey Please Audit our Investment Strategy. Wife (36YO) Me (35YO)

My Wife and I are actively trying to improve our financial situation, and set our child (2yo) up so that he is financially well off as well. We both now work in the Software/Crypto industry, earning a combined gross salary of around ~$220k. Our Goal is to be more FI so that we can pursue things we enjoy, rather than working our corporate jobs. We'd also like to RE, but wouldn't mind putting this off so long as we're doing something we love.
Investment accounts: $495,000
Monthly Expenses: ~$8k
Monthly Leftover for Contributions: ~$2k
Home Value: ~$800,000 with $243,079.08 left on mortgage @ 2.625% 15 Year mortgage (11 year(s) remaining)
Other accounts:
I recently left my Corporate job and am now a full time Crypto Engineer, so I no long have access to 401k's from a company but My wife maxes out her 401K. I still invest $200 a month into my sons 529. My Wife also now handles all of the insurance after I left my job, so she's now contributing to our HSA.
Strategies:
Questions:
submitted by seemsdicey to Fire [link] [comments]


2024.06.05 17:19 jjdewit Deriv.com Broker Review: A Full Guide By A Seasoned Trader

Deriv.com.com is a leading provider of financial services, specializing in the development and provision of innovative trading solutions. With a rich history spanning over a decade, Deriv.com has established itself as a trusted and reliable partner for individuals, institutions, and businesses seeking to navigate the complexities of the financial markets.

Early Years and Founding

Deriv.com was founded in 2009 by a group of visionary entrepreneurs who shared a passion for innovation and a commitment to excellence. The company's early years were marked by a focus on developing cutting-edge trading platforms and tools, which quickly gained popularity among traders and investors. As the company grew, Deriv.com expanded its offerings to include a range of financial products and services, solidifying its position as a major player in the financial services industry.

Mission and Values

At Deriv.com, our mission is to empower individuals and institutions to achieve their financial goals by providing access to innovative trading solutions, exceptional customer service, and unparalleled market insights. We are committed to fostering a culture of innovation, integrity, and collaboration, and to building long-term relationships with our clients and partners.
Our values are rooted in a deep understanding of the importance of trust, transparency, and accountability. We believe that our success is directly tied to the success of our clients, and we are dedicated to delivering exceptional value and results. Our commitment to excellence is reflected in every aspect of our business, from the development of our products and services to the way we interact with our clients and partners.

Key Milestones

Throughout its history, Deriv.com has achieved numerous milestones that have solidified its position as a leader in the financial services industry. Some of the company's key milestones include:
· 2009: Deriv.com is founded by a group of entrepreneurs with a vision to revolutionize the financial services industry.
· 2012: Deriv.com launches its flagship trading platform, which quickly gains popularity among traders and investors.
· 2015: Deriv.com expands its offerings to include a range of financial products and services, including forex, commodities, and indices.
· 2018: Deriv.com launches its mobile trading app, providing clients with the ability to trade on-the-go.
· 2020: Deriv.com is recognized as one of the fastest-growing companies in the financial services industry.

Awards and Recognition

Deriv.com has received numerous awards and recognition for its innovative products and services, exceptional customer service, and commitment to excellence. Some of the company's notable awards include:
· 2019: Deriv.com is recognized as the "Best Trading Platform" by Financial Times.
· 2020: Deriv.com is named one of the "Top 10 Financial Services Companies" by Forbes.
· 2020: Deriv.com receives the "Excellence in Customer Service" award from the International Association of Financial Services.

Conclusion

In conclusion, Deriv.com's history and mission are deeply rooted in a commitment to innovation, excellence, and customer satisfaction. With a rich history spanning over a decade, Deriv.com has established itself as a trusted and reliable partner for individuals, institutions, and businesses seeking to navigate the complexities of the financial markets. As we look to the future, we remain committed to our mission of empowering individuals and institutions to achieve their financial goals, and to building long-term relationships with our clients and partners.

Regulations and Licenses

As a leading provider of financial services, Deriv.com takes its regulatory obligations seriously and is committed to ensuring compliance with all relevant laws and regulations. In this chapter, we will provide an overview of our regulatory licenses and memberships, highlighting our commitment to transparency and accountability.

Regulatory Licenses

Deriv.com holds the following regulatory licenses:
· Gibraltar Financial Services Commission (GFSC): Deriv.com is licensed by the GFSC, the financial regulator of Gibraltar, under the Financial Services (Markets in Financial Instruments) Regulations 2017. This license allows us to provide financial services, including trading in financial instruments, to clients worldwide.
· Cyprus Securities and Exchange Commission (CySEC): Deriv.com is also licensed by CySEC, the financial regulator of Cyprus, under the Investment Services and Activities and Regulated Markets Law of 2007. This license enables us to provide investment services, including trading in financial instruments, to clients in the European Union.

Membership and Compliance

Deriv.com is a member of the following organizations:
· FCA (Financial Conduct Authority): As a member of the FCA, Deriv.com is subject to the FCA's rules and regulations, which aim to protect consumers and ensure the integrity of the financial markets.
· ESMA (European Securities and Markets Authority): As a member of ESMA, Deriv.com is subject to the ESMA's guidelines and regulations, which aim to promote investor protection and ensure the stability of the financial markets.
· International Organization of Securities Commissions (IOSCO): Deriv.com is a member of IOSCO, an international organization that aims to promote cooperation and coordination among securities regulators worldwide.

Compliance Framework

Deriv.com has a comprehensive compliance framework in place to ensure compliance with all relevant regulations and laws. Our compliance framework includes:
· Risk Management: Deriv.com has a robust risk management framework in place to identify, assess, and mitigate risks associated with our business activities.
· Anti-Money Laundering (AML) and Combating the Financing of Terrorism (CFT): Deriv.com has implemented an AML/CFT program to prevent and detect money laundering and terrorist financing activities.
· Data Protection: Deriv.com is committed to protecting the personal data of our clients and employees, and has implemented a data protection framework that complies with the General Data Protection Regulation (GDPR).

Transparency and Accountability

Deriv.com is committed to transparency and accountability, and we strive to maintain the highest standards of governance and ethics. We believe that transparency is essential for building trust with our clients and stakeholders, and we are committed to providing clear and timely information about our business activities and financial performance.

Conclusion

In conclusion, Deriv.com is committed to complying with all relevant regulations and laws, and we take our regulatory obligations seriously. Our regulatory licenses and memberships demonstrate our commitment to transparency and accountability, and we are proud to be a leading provider of financial services.

MT5

The MetaTrader 5 (MT5) platform is a powerful and feature-rich trading platform designed for online trading and technical analysis. Developed by MetaQuotes, MT5 is widely used by traders, brokers, and financial institutions around the world. In this chapter, we will delve into the features and benefits of the MT5 platform, highlighting its capabilities, advantages, and applications.

Features of MT5

1. Trading Platform: MT5 is a comprehensive trading platform that allows users to trade financial instruments, including forex, stocks, futures, and CFDs. It provides a user-friendly interface for placing trades, managing positions, and monitoring account activity.
2. Technical Analysis: MT5 offers a range of technical indicators and charting tools, enabling traders to analyze market trends, identify patterns, and make informed trading decisions. The platform supports multiple chart types, including line charts, candlestick charts, and Renko charts.
3. Automated Trading: MT5 allows users to create and backtest their own trading strategies using the MQL5 programming language. This feature enables traders to automate their trading decisions, reducing the risk of human error and increasing the potential for profitable trades.
4. Market Data: MT5 provides real-time market data, including quotes, news, and analytics. This information helps traders stay informed about market trends, news, and events that may impact their trading decisions.
5. Account Management: MT5 allows users to manage their trading accounts, including depositing and withdrawing funds, monitoring account balances, and setting account limits.
6. Security: MT5 employs advanced security measures to protect user accounts and data, including encryption, firewalls, and access controls.
7. Multi-Lingual Support: MT5 is available in multiple languages, making it accessible to traders worldwide.

Benefits of MT5

1. Flexibility: MT5 offers a range of trading instruments, allowing users to trade a variety of financial instruments across multiple markets.
2. Customization: The platform's customizable interface and settings enable traders to tailor their trading experience to their individual needs.
3. Automation: MT5's automated trading capabilities enable traders to automate their trading strategies, reducing the risk of human error and increasing the potential for profitable trades.
4. Real-Time Data: MT5 provides real-time market data, enabling traders to make informed trading decisions based on current market conditions.
5. Security: MT5's advanced security measures protect user accounts and data, providing a secure trading environment.
6. Scalability: MT5 is designed to handle high volumes of trading activity, making it suitable for both individual traders and institutional clients.
7. Community: MT5 has a large and active community of traders, providing a platform for users to share knowledge, strategies, and ideas.

Applications of MT5

1. Retail Trading: MT5 is widely used by individual traders, allowing them to trade a variety of financial instruments and manage their trading accounts.
2. Institutional Trading: MT5 is used by institutional clients, such as banks, brokerages, and hedge funds, to manage their trading operations and provide trading services to their clients.
3. Algorithmic Trading: MT5's automated trading capabilities make it an ideal platform for algorithmic traders, who can create and backtest their own trading strategies.
4. Market Making: MT5's real-time market data and automated trading capabilities make it suitable for market makers, who can use the platform to provide liquidity and manage their trading operations.
5. Research and Development: MT5's programming language and automated trading capabilities make it an ideal platform for researchers and developers, who can use the platform to test and develop new trading strategies and algorithms.
In conclusion, MT5 is a powerful and feature-rich trading platform that offers a range of benefits and applications. Its flexibility, customization options, and automated trading capabilities make it an ideal platform for traders, brokers, and financial institutions. Whether used for retail trading, institutional trading, algorithmic trading, or market making, MT5 provides a comprehensive and secure trading environment for users.

DBot

In today's digital age, artificial intelligence (AI) and machine learning (ML) have revolutionized the way businesses operate. One such innovation is the DBot platform, a cutting-edge technology that has transformed the way companies interact with their customers. In this chapter, we will delve into the features and benefits of the DBot platform, exploring its capabilities and advantages in the context of customer service and support.

Overview of DBot Platform

DBot is a cloud-based platform that utilizes natural language processing (NLP) and machine learning algorithms to enable businesses to provide personalized customer service and support. The platform is designed to simulate human-like conversations, allowing customers to interact with a virtual assistant that can understand and respond to their queries in a natural and intuitive manner.

Key Features of DBot Platform

1. Conversational Interface: DBot's conversational interface allows customers to interact with the platform through voice or text-based conversations, making it easy for them to seek assistance and resolve their queries.
2. Natural Language Processing (NLP): DBot's NLP capabilities enable the platform to understand and interpret customer queries, allowing it to provide accurate and relevant responses.
3. Machine Learning: DBot's machine learning algorithms enable the platform to learn from customer interactions, improving its performance and accuracy over time.
4. Integration with CRM Systems: DBot integrates seamlessly with customer relationship management (CRM) systems, allowing businesses to access customer data and provide personalized support.
5. Multi-Channel Support: DBot supports multiple channels, including voice, text, and messaging apps, making it easy for customers to interact with the platform across various platforms.

Benefits of DBot Platform

1. Improved Customer Experience: DBot's conversational interface and NLP capabilities enable businesses to provide personalized and efficient customer service, leading to improved customer satisfaction and loyalty.
2. Increased Efficiency: DBot's automation capabilities reduce the need for human intervention, freeing up customer support agents to focus on complex issues and high-value tasks.
3. Cost Savings: By automating routine customer inquiries, businesses can reduce the need for human customer support agents, resulting in significant cost savings.
4. Enhanced Data Analysis: DBot's machine learning algorithms provide businesses with valuable insights into customer behavior and preferences, enabling data-driven decision-making.
5. Scalability: DBot's cloud-based platform allows businesses to scale their customer support operations quickly and efficiently, without the need for significant infrastructure investments.

Conclusion

In conclusion, the DBot platform offers a powerful and innovative solution for businesses looking to improve their customer service and support operations. With its conversational interface, NLP capabilities, and machine learning algorithms, DBot provides a personalized and efficient customer experience, while reducing costs and improving data analysis. As the DBot platform continues to evolve and improve, it is poised to revolutionize the way businesses interact with their customers, providing a competitive edge in today's fast-paced and increasingly digital marketplace.

Deriv.com GO

As a trader, you're always on the lookout for an edge that sets you apart from the competition. Deriv.com GO is the ultimate trading platform that empowers you to take your trading to the next level. In this chapter, we'll delve into the features and benefits of Deriv.com GO, showcasing how it can revolutionize your trading experience.

Advanced Trading Features

Deriv.com GO is designed to provide traders with a comprehensive set of tools to help them make informed decisions. Here are some of the key features that set it apart:
1. Multi-Asset Trading: Deriv.com GO offers trading in a wide range of assets, including Forex, Cryptocurrencies, Commodities, Indices, and Stocks. This diverse range of assets allows traders to diversify their portfolios and capitalize on market trends.
2. Advanced Charting Tools: Deriv.com GO's charting system is equipped with advanced features such as multiple chart types, customizable indicators, and real-time market data. This enables traders to analyze market trends and make data-driven decisions.
3. Algorithmic Trading: Deriv.com GO's algorithmic trading feature allows traders to automate their trading strategies, reducing the risk of human error and increasing the potential for profit.
4. Risk Management: Deriv.com GO's risk management system provides traders with the ability to set stop-loss orders, limit their exposure, and manage their positions effectively.
5. Mobile Trading: Deriv.com GO's mobile app allows traders to stay connected to the markets and trade on-the-go, ensuring that they never miss an opportunity.

Benefits of Deriv.com GO

Deriv.com GO's advanced features and benefits provide traders with a competitive edge in the market. Here are some of the key benefits:
1. Increased Trading Efficiency: Deriv.com GO's advanced trading features and tools enable traders to make faster and more informed decisions, increasing their trading efficiency.
2. Improved Risk Management: Deriv.com GO's risk management system helps traders to manage their positions effectively, reducing their exposure to market volatility and potential losses.
3. Enhanced Trading Experience: Deriv.com GO's user-friendly interface and advanced features provide traders with a seamless and enjoyable trading experience.
4. Increased Profit Potential: Deriv.com GO's algorithmic trading feature and advanced charting tools enable traders to capitalize on market trends and increase their profit potential.
5. 24/7 Customer Support: Deriv.com GO's dedicated customer support team is available 24/7 to assist traders with any queries or issues they may have.

Conclusion

Deriv.com GO is the ultimate trading platform for traders who demand the best. With its advanced features and benefits, Deriv.com GO provides traders with the tools they need to succeed in today's fast-paced markets. Whether you're a seasoned trader or just starting out, Deriv.com GO is the perfect platform to help you achieve your trading goals.

Forex

The foreign exchange market, commonly referred to as the forex market, is a global marketplace where individuals, businesses, and institutions trade currencies. The forex market is the largest and most liquid market in the world, with a daily trading volume of over $6 trillion. In this chapter, we will delve into the world of forex trading, exploring the basics of forex trading, the benefits of trading with Deriv.com, and the steps to get started with forex trading.

What is Forex Trading?

Forex trading involves buying and selling currencies in the foreign exchange market. The value of a currency is determined by supply and demand, and it is influenced by various economic factors such as interest rates, inflation, and political events. Forex traders aim to profit from the fluctuations in currency values by buying and selling currencies at the right time.

How Does Forex Trading Work?

Forex trading involves the exchange of one currency for another. The exchange rate is the price of one currency in terms of another. For example, if the exchange rate is 1 USD = 0.80 EUR, it means that one US dollar can be exchanged for 0.80 euros. Forex traders use leverage to amplify their gains, allowing them to control larger positions with a smaller amount of capital.

Types of Forex Trading

There are several types of forex trading strategies, including:
1. Day Trading: This involves buying and selling currencies within a single trading day, with the goal of making a profit from the fluctuations in the market.
2. Swing Trading: This involves holding positions for a longer period, typically several days or weeks, to profit from the fluctuations in the market.
3. Position Trading: This involves holding positions for a longer period, typically several weeks or months, to profit from the long-term trends in the market.

Benefits of Trading with Deriv.com

Deriv.com is a popular online trading platform that offers a range of benefits to forex traders, including:
1. Low Spreads: Deriv.com offers competitive spreads, allowing traders to save on trading costs.
2. Leverage: Deriv.com offers leverage of up to 1:500, allowing traders to amplify their gains.
3. Wide Range of Currencies: Deriv.com offers a wide range of currencies, including major, minor, and exotic currencies.
4. Advanced Trading Tools: Deriv.com offers advanced trading tools, including technical indicators, charts, and analytics.
5. 24/5 Customer Support: Deriv.com offers 24/5 customer support, providing traders with assistance whenever they need it.

Getting Started with Forex Trading with Deriv.com

To get started with forex trading with Deriv.com, follow these steps:
1. Create an Account: Go to the Deriv.com website and create an account by filling out the registration form.
2. Verify Your Account: Verify your account by providing identification documents and proof of address.
3. Fund Your Account: Fund your account using a range of payment methods, including credit cards, e-wallets, and bank transfers.
4. Choose a Trading Platform: Choose a trading platform that suits your trading style, including the Deriv.com WebTrader, Deriv.com Mobile App, or MetaTrader 4.
5. Start Trading: Start trading by selecting a currency pair, setting your trade size, and executing your trade.

Conclusion

Forex trading is a complex and dynamic market that requires a deep understanding of the market and its participants. Trading with Deriv.com offers a range of benefits, including low spreads, leverage, and advanced trading tools. By following the steps outlined in this chapter, you can get started with forex trading and take advantage of the opportunities offered by the forex market.

Stock CFDs

In the world of financial markets, trading with Contracts for Difference (CFDs) has become increasingly popular among investors and traders. CFDs offer a unique way to trade on the price movements of various assets, including stocks, indices, commodities, and currencies. In this chapter, we will delve into the world of stock CFD trading, exploring the concept, benefits, and risks associated with trading stock CFDs with Deriv.com.

What are Stock CFDs?

A Stock CFD is a Deriv.comative financial instrument that allows traders to speculate on the price movements of individual stocks. It is a contract between two parties, where one party agrees to pay the difference between the current market price and the price at which the contract was entered into. Stock CFDs are traded on margin, allowing traders to control a large position with a relatively small amount of capital.

How do Stock CFDs work?

Trading stock CFDs with Deriv.com involves the following steps:
1. Opening a trading account: To start trading stock CFDs, you need to open a trading account with a reputable broker, such as Deriv.com.
2. Choosing a stock: Select the stock you want to trade, taking into account factors such as market trends, news, and technical analysis.
3. Setting a position: Decide on the direction of the trade, either buying (going long) or selling (going short).
4. Setting a stop-loss: Set a stop-loss order to limit potential losses in case the trade does not go in your favor.
5. Monitoring and adjusting: Monitor the trade and adjust the position as needed to maximize profits or minimize losses.
6. Closing the position: Close the trade when the desired profit target is reached or when the trade no longer aligns with your investment strategy.

Benefits of Trading Stock CFDs

Trading stock CFDs with Deriv.com offers several benefits, including:
1. Leverage: Trade with leverage, allowing you to control a large position with a relatively small amount of capital.
2. Flexibility: Trade on both rising and falling markets, allowing you to profit from both bullish and bearish trends.
3. Reduced transaction costs: Trading CFDs eliminates the need to physically buy or sell the underlying stock, reducing transaction costs.
4. Increased liquidity: CFDs are traded on margin, allowing for increased liquidity and tighter spreads.
5. 24/5 trading: Trade on stock CFDs 24 hours a day, 5 days a week, allowing you to react quickly to market movements.

Risks of Trading Stock CFDs

While trading stock CFDs with Deriv.com offers many benefits, it also carries significant risks, including:
1. Leverage: Trading with leverage amplifies both profits and losses, making it essential to manage risk effectively.
2. Market volatility: Stock prices can fluctuate rapidly, resulting in significant losses if not managed properly.
3. Counterparty risk: Trading with a CFD provider, such as Deriv.com, involves counterparty risk, where the provider may default on their obligations.
4. Market manipulation: Market manipulation can occur, resulting in significant losses if not monitored closely.

Conclusion

Trading stock CFDs with Deriv.com offers a unique way to speculate on the price movements of individual stocks. While it carries significant risks, it also provides opportunities for traders to profit from both rising and falling markets. By understanding the benefits and risks associated with trading stock CFDs, traders can make informed decisions and manage their risk effectively.

Cryptocurrencies

Cryptocurrencies have revolutionized the financial landscape in recent years, offering a new and innovative way for individuals to invest and trade. With the rise of digital currencies, the concept of cryptocurrency trading has become increasingly popular, attracting investors from all over the world. In this chapter, we will delve into the world of cryptocurrency trading, exploring the concept of cryptocurrency trading with Deriv.com, a leading online trading platform.

What are Cryptocurrencies?

Before diving into the world of cryptocurrency trading, it is essential to understand what cryptocurrencies are. Cryptocurrencies are digital or virtual currencies that use cryptography for secure financial transactions. They are decentralized, meaning that they are not controlled by any government or institution, and are based on a decentralized network of computers that verify and record transactions.

Types of Cryptocurrencies

There are numerous types of cryptocurrencies, each with its unique features and characteristics. Some of the most popular cryptocurrencies include:
1. Bitcoin (BTC): The first and most well-known cryptocurrency, Bitcoin is the largest and most widely traded cryptocurrency.
2. Ethereum (ETH): A decentralized platform that enables the creation of smart contracts and decentralized applications.
3. Litecoin (LTC): A peer-to-peer cryptocurrency that is similar to Bitcoin but with faster transaction processing times.
4. Ripple (XRP): A real-time gross settlement system (RTGS) and currency exchange and remittance network by Ripple.

Cryptocurrency Trading with Deriv.com

Deriv.com is a leading online trading platform that offers cryptocurrency trading services to individuals and institutions. With Deriv.com, users can trade a wide range of cryptocurrencies, including Bitcoin, Ethereum, Litecoin, and Ripple. Deriv.com offers a user-friendly interface, making it easy for beginners to start trading cryptocurrencies.

Benefits of Trading Cryptocurrencies with Deriv.com

Trading cryptocurrencies with Deriv.com offers several benefits, including:
1. Accessibility: Deriv.com offers a user-friendly interface, making it easy for individuals to start trading cryptocurrencies.
2. Security: Deriv.com uses advanced security measures to protect user accounts and transactions.
3. Leverage: Deriv.com offers leverage, allowing traders to amplify their gains and losses.
4. Variety of Cryptocurrencies: Deriv.com offers a wide range of cryptocurrencies to trade, including Bitcoin, Ethereum, Litecoin, and Ripple.
5. Competitive Spreads: Deriv.com offers competitive spreads, making it an attractive option for traders.

Getting Started with Cryptocurrency Trading with Deriv.com

To get started with cryptocurrency trading with Deriv.com, follow these steps:
1. Create an Account: Go to the Deriv.com website and create an account.
2. Verify Your Account: Verify your account by providing identification documents.
3. Deposit Funds: Deposit funds into your account using a variety of payment methods.
4. Choose a Cryptocurrency: Choose the cryptocurrency you want to trade.
5. Set Your Trade: Set your trade by specifying the amount, leverage, and stop-loss.
6. Monitor Your Trade: Monitor your trade and adjust as needed.
submitted by jjdewit to beststockbrokers [link] [comments]


2024.06.05 17:12 ThielschATX [HIRING] Entry-Level Field Engineer - Austin

https://www.paycomonline.net/v4/ats/web.php/jobs/ViewJobDetails?clientkey=F097062E81F6512CC789734822344027&job=101529&jpt=

Job Details

Job Location: Del Valle, TX
Position Type: Full Time
Education Level: 4 Year Degree
Salary Range: $55,000.00 - $75,000.00 Base+Commission/year
Travel Percentage: Road Warrior
Job Shift: Any
Job Category: Engineering
Job Opportunity - Field Engineer Field Engineering Services, a division of RISE Group, Inc. is seeking a highly motivated individual to fill our Field Engineer role. The Field Engineer will conduct hands-on field inspections of power boilers, pressure vessels, power piping, steam turbines, and related critical components. The successful candidate is willing to learn and apply project management, nondestructive testing, metallurgy, and applicable codes and standards for the power generation and process industries. This position requires *extensive* travel.
Essential Duties and Responsibilities:
Qualifications:
Travel

Compensation & Benefits
View full job description at: https://www.paycomonline.net/v4/ats/web.php/jobs/ViewJobDetails?clientkey=F097062E81F6512CC789734822344027&job=101529&jpt=
submitted by ThielschATX to forhire [link] [comments]


2024.06.05 17:10 ThielschATX [HIRING] Entry-Level Field Engineer

https://www.paycomonline.net/v4/ats/web.php/jobs/ViewJobDetails?clientkey=F097062E81F6512CC789734822344027&job=101529&jpt=

Job Details

Job Location: Del Valle, TX
Position Type: Full Time
Education Level: 4 Year Degree
Salary Range: $55,000.00 - $75,000.00 Base+Commission/year
Travel Percentage: Road Warrior
Job Shift: Any
Job Category: Engineering
Job Opportunity - Field Engineer Field Engineering Services, a division of RISE Group, Inc. is seeking a highly motivated individual to fill our Field Engineer role. The Field Engineer will conduct hands-on field inspections of power boilers, pressure vessels, power piping, steam turbines, and related critical components. The successful candidate is willing to learn and apply project management, nondestructive testing, metallurgy, and applicable codes and standards for the power generation and process industries. This position requires *extensive* travel.
Essential Duties and Responsibilities:
Qualifications:
Travel

Compensation & Benefits
View full job description at: https://www.paycomonline.net/v4/ats/web.php/jobs/ViewJobDetails?clientkey=F097062E81F6512CC789734822344027&job=101529&jpt=
submitted by ThielschATX to austinjobs [link] [comments]


http://rodzice.org/